Ryvu Therapeutics SA

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 20.81% vs 20.16% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 28.74% vs 26.71% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "18.00",
          "val2": "14.90",
          "chgp": "20.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-22.70",
          "val2": "-26.80",
          "chgp": "15.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.10",
          "val2": "2.10",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.30",
          "val2": "1.60",
          "chgp": "-81.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-17.60",
          "val2": "-24.70",
          "chgp": "28.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,362.70%",
          "val2": "-1,989.30%",
          "chgp": "62.66%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -20.13% vs 66.31% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 9.16% vs -20.96% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "62.30",
          "val2": "78.00",
          "chgp": "-20.13%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-112.70",
          "val2": "-135.30",
          "chgp": "16.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "8.80",
          "val2": "3.80",
          "chgp": "131.58%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.70",
          "val2": "6.70",
          "chgp": "-110.45%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-101.20",
          "val2": "-111.40",
          "chgp": "9.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,962.20%",
          "val2": "-1,869.60%",
          "chgp": "-9.26%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

18.00

14.90

20.81%

Operating Profit (PBDIT) excl Other Income

-22.70

-26.80

15.30%

Interest

2.10

2.10

Exceptional Items

0.30

1.60

-81.25%

Consolidate Net Profit

-17.60

-24.70

28.74%

Operating Profit Margin (Excl OI)

-1,362.70%

-1,989.30%

62.66%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is 20.81% vs 20.16% in Sep 2025

Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is 28.74% vs 26.71% in Sep 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

62.30

78.00

-20.13%

Operating Profit (PBDIT) excl Other Income

-112.70

-135.30

16.70%

Interest

8.80

3.80

131.58%

Exceptional Items

-0.70

6.70

-110.45%

Consolidate Net Profit

-101.20

-111.40

9.16%

Operating Profit Margin (Excl OI)

-1,962.20%

-1,869.60%

-9.26%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -20.13% vs 66.31% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 9.16% vs -20.96% in Dec 2024

All Annual Results